TickerFactsScreenerDevelopers

BIOGEN INC. (BIIB) — Cost of Revenue

Annual figures by fiscal year, from SEC filings.

2016: $1.48B2017: $1.63B2018: $1.82B2019: $1.96B2020: $1.81B2021: $2.11B2022: $2.28B2023: $2.53B2024: $2.31B2025: $2.40B$2.40B
2016Cost of Revenue (USD)2025
Fiscal YearCost of RevenueChange YoY
2025$2.40B+4.1%
2024$2.31B-8.8%
2023$2.53B+11.2%
2022$2.28B+8.0%
2021$2.11B+16.9%
2020$1.81B-7.7%
2019$1.96B+7.7%
2018$1.82B+11.4%
2017$1.63B+10.2%
2016$1.48B—